OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	309
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	284
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	276
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	229
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	228
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	177
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	170
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	163
Intestinal bacteria and colorectal cancer: etiology and treatment	160
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	145
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	145
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	142
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	140
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	129
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	123
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	121
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	121
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	119
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	118
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	108
Effect of diet on the evolution of gut commensal bacteria	106
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	105
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	99
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	97
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	97

Modeling spatial interaction networks of the gut microbiota	97
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	96
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	94
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	93
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	92
Metabolic modeling links gut microbiota to metabolic markers of Parkinson’s disease	92
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	90
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	88
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	87
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	87
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	87
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	86
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	85
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	84
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	84
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	83
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data	83
The emerging role of the gut microbiota in vaccination responses	83
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	82
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	81
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	81
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	80
Engineered bacteria as an orally administered anti-viral treatment and immunization system	80
Akkermansia in the gastrointestinal tract as a modifier of human health	80
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	79
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	78
Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled tr	78
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	76
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	75
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	74
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	74
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	73
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	72
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	72
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	70
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	69
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	67
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	67
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	66
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	66
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	66